Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyunkyoung Kim

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2025
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2023
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
ERJ Open Research|August 28, 2025
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthmaDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
The World Allergy Organization Journal|December 6, 2024
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatmentDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Allergy and Clinical Immunology. in Practice|March 20, 2025
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma StudyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2023
Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM studyDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
ERJ Open Research|August 28, 2025
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthmaDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
The World Allergy Organization Journal|December 6, 2024
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatmentDuong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, et al.
Pageof 3